首页|参芪健脾益肾汤加减联合缬沙坦胶囊治疗慢性肾小球肾炎患者的效果观察

参芪健脾益肾汤加减联合缬沙坦胶囊治疗慢性肾小球肾炎患者的效果观察

扫码查看
目的:分析慢性肾小球肾炎(CGN)患者联合使用缬沙坦胶囊、参芪健脾益肾汤加减的疗效.方法:选取本院中西医结合肾内科2021年3月—2022年3月收治的CGN患者82例,随机分为A组(41例,缬沙坦胶囊)和B组(41例,缬沙坦胶囊+参芪健脾益肾汤加减),比较两组临床疗效、中医证候积分、肾功能指标、免疫功能指标、炎性因子指标.结果:B组治疗有效率为 95.12%,高于A组的 78.05%,差异有统计学意义(P<0.05);B组治疗后中医证候积分、肾功能指标、免疫功能指标、炎性因子指标均优于A组,差异有统计学意义(P<0.05).结论:CGN患者联合使用缬沙坦胶囊、参芪健脾益肾汤加减能取得更加理想的治疗效果,且在改善临床症状、肾功能、免疫功能、炎性反应方面具有积极作用.
Observation on the Effect of Modified Shenqi Jianpi Yishen Decoction Combined with Valsartan Capsule in the Treatment of Patients with Chronic Glomerulonephritis
Objective:To analyze the efficacy of valsartan capsules combined with modified Shenqi Jianpi Yishen decoction in patients with chronic glomerulonephritis(CGN).Methods:A total of 82 CGN patients admitted to the Department of Nephropathy of Integrated Chinese and Western Medicine in our hospital from March 2021 to March 2022 were randomly divided into group A(41 patients with valsartan capsule)and group B(41 patients with valsartan capsule plus modified Shenqi Jianpi Yishen decoction).The clinical efficacy,TCM syndrome score,renal function index,immune function index and inflammatory factor index of the two groups were compared.Results:The effective rate of group B was 95.12%,which was higher than 78.05%of group A,the difference was statistically significant(P<0.05).After treatment,the TCM syndrome score,renal function index,immune function index and inflammatory factor index in group B were better than those in group A,and the differences were statistically significant(P<0.05).Conclusion:The combination of valsartan capsule and modified Shenqi Jianpi Yishen decoction can achieve more ideal therapeutic effect in CGN patients,and has positive effects on improving clinical symptoms,renal function,immune function and inflammatory response.

Chronic glomerulonephritisValsartan capsulesModified Shenqi Jianpi Yishen decoctionImmune function

雷帅兵、李江、闫恒阳、李玉春

展开 >

南召县人民医院中西医结合肾内科,河南 南阳 474650

南召县人民医院心血管内科一病区,河南 南阳 474650

慢性肾小球肾炎 缬沙坦胶囊 参芪健脾益肾汤加减 免疫功能

2024

中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
年,卷(期):2024.30(6)
  • 8